Spots Global Cancer Trial Database for allogeneic bone marrow transplantation

Every month we try and update this database with for allogeneic bone marrow transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia	NCT00453388	Acute Myeloid L... de Novo Myelody... Fanconi Anemia Previously Trea...	Allogeneic Bone... Cyclophosphamid... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Nonmyeloablativ... Total-Body Irra...	-	Fred Hutchinson Cancer Center
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation	NCT00052520	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... B-cell Adult Ac... B-cell Childhoo... Childhood Chron... Childhood Myelo... Chronic Myelomo... Essential Throm... Polycythemia Ve... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... T-cell Adult Ac... T-cell Childhoo...	therapeutic all... aldesleukin peripheral bloo... allogeneic bone... laboratory biom... gene expression... immunologic tec... flow cytometry polymerase chai... cytogenetic ana... staining method	-	Fred Hutchinson Cancer Center
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia	NCT00003868	Leukemia	cyclophosphamid... methotrexate allogeneic bone... peripheral bloo... iodine I 131 mo... radiation thera...	2 Years - 55 Years	Fred Hutchinson Cancer Center
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia	NCT00002549	Leukemia	filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant	NCT02333162	Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Hemat...	Fludarabine Pho... Melphalan Intensity-Modul... Total Marrow Ir... Allogeneic Hema... Peripheral Bloo... Allogeneic Bone... Tacrolimus Mycophenolate M... Laboratory Biom...	18 Years - 75 Years	University of Chicago
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS	NCT01300572	Chronic Myelomo... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Secondary Acute...	Allogeneic Bone... Allogeneic Hema... Cyclosporine Fludarabine Pho... Indium In 111 A... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Pharmacological... Total-Body Irra... Yttrium Y 90 An...	18 Years -	Fred Hutchinson Cancer Center
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia	NCT00002785	Leukemia	filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine mesna methotrexate methylprednisol... pegaspargase prednisone therapeutic hyd... vincristine sul... allogeneic bone... low-LET cobalt-... low-LET photon ...	- 1 Year	Children's Oncology Group
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis	NCT02528877	Acute Myeloid L... Primary Myelofi... Primary Myelofi... Secondary Acute... Secondary Myelo...	Allogeneic Bone... Allogeneic Hema... Fludarabine Pho... Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Ruxolitinib Pho... Sirolimus Tacrolimus	18 Years - 75 Years	City of Hope Medical Center
Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission	NCT00005940	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye...	iodine I 131 mo... busulfan cyclophosphamid... allogeneic bone... allogeneic hema... peripheral bloo... cyclosporine methotrexate laboratory biom...	16 Years - 55 Years	Fred Hutchinson Cancer Center
Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma	NCT00003195	Multiple Myelom...	recombinant int... busulfan allogeneic bone... peripheral bloo... radiation thera...	18 Years - 65 Years	Fred Hutchinson Cancer Center
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia	NCT00550992	Leukemia	anti-thymocyte ... asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide leucovorin calc... melphalan mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisolone prednisone therapeutic hyd... thioguanine vincristine sul... allogeneic bone... allogeneic hema... umbilical cord ...	- 1 Year	Dutch Childhood Oncology Group
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS	NCT01300572	Chronic Myelomo... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Secondary Acute...	Allogeneic Bone... Allogeneic Hema... Cyclosporine Fludarabine Pho... Indium In 111 A... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Pharmacological... Total-Body Irra... Yttrium Y 90 An...	18 Years -	Fred Hutchinson Cancer Center
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia	NCT00003758	Leukemia	cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo...	15 Years - 60 Years	National Cancer Institute (NCI)
Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma	NCT00003195	Multiple Myelom...	recombinant int... busulfan allogeneic bone... peripheral bloo... radiation thera...	18 Years - 65 Years	Fred Hutchinson Cancer Center
Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission	NCT00005940	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye...	iodine I 131 mo... busulfan cyclophosphamid... allogeneic bone... allogeneic hema... peripheral bloo... cyclosporine methotrexate laboratory biom...	16 Years - 55 Years	Fred Hutchinson Cancer Center
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission	NCT00305708	Congenital Ameg... Diamond-blackfa... Fanconi Anemia Leukemia Severe Congenit... Thrombocytopeni...	anti-thymocyte ... busulfan fludarabine pho... allogeneic bone... peripheral bloo... umbilical cord ... radiation thera...	- 17 Years	University of California, San Francisco
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT01707004	Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Previously Trea... Recurrent Adult... Secondary Acute...	decitabine fludarabine pho... busulfan cyclophosphamid... tacrolimus mycophenolate m... filgrastim total-body irra... allogeneic bone... laboratory biom...	18 Years - 75 Years	University of Wisconsin, Madison
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant	NCT02333162	Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Hemat...	Fludarabine Pho... Melphalan Intensity-Modul... Total Marrow Ir... Allogeneic Hema... Peripheral Bloo... Allogeneic Bone... Tacrolimus Mycophenolate M... Laboratory Biom...	18 Years - 75 Years	University of Chicago
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers	NCT00003572	Leukemia Lymphoma Multiple Myelom... Myelodysplastic...	peripheral bloo... mycophenolate m... tacrolimus allogeneic bone... radiation thera...	18 Years - 70 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome	NCT00024050	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone... peripheral bloo...	- 65 Years	Fred Hutchinson Cancer Center
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation	NCT00005641	Chronic Myelopr... Graft Versus Ho... Leukemia Multiple Myelom... Myelodysplastic...	anti-thymocyte ... busulfan cyclophosphamid... cyclosporine leucovorin calc... methotrexate methylprednisol... allogeneic bone... in vitro-treate... radiation thera...	15 Years - 60 Years	H. Lee Moffitt Cancer Center and Research Institute
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia	NCT00002549	Leukemia	filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)	NCT01379209	Graft Versus Ho...	RGI-2001 Calcineurin Inh... Allogeneic Hema... Conditioning Re... Allogeneic Bone... Methotrexate Mofetil Mycophe... sirolimus	18 Years -	Regimmune Corporation
S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia	NCT00005866	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone... radiation thera...	16 Years - 55 Years	SWOG Cancer Research Network
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia	NCT00002771	Leukemia	recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera...	-	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia	NCT00002926	Leukemia Myelodysplastic...	cytarabine etoposide idarubicin allogeneic bone... peripheral bloo...	16 Years - 60 Years	National Cancer Institute (NCI)
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia	NCT00093743	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Myelo... Fanconi Anemia Previously Trea...	fludarabine pho... cyclosporine total-body irra... allogeneic bone... allogeneic hema... peripheral bloo... mycophenolate m...	-	Fred Hutchinson Cancer Center
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia	NCT00002531	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone teniposide thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo... radiation thera...	15 Years - 65 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia	NCT00003436	Leukemia Myelodysplastic...	amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone...	- 15 Years	National Cancer Institute (NCI)
Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia	NCT00002844	Leukemia	Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra...	16 Years - 65 Years	M.D. Anderson Cancer Center
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia	NCT00022737	Childhood Acute... Recurrent Child...	filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide ifosfamide imatinib mesyla... leucovorin calc... mercaptopurine ... methotrexate pegaspargase vincristine sul... allogeneic bone... peripheral bloo... umbilical cord ... radiation thera...	1 Year - 21 Years	National Cancer Institute (NCI)
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia	NCT01008462	B-Cell Prolymph... Hypodiploidy Loss of Chromos... Plasma Cell Leu... Progression of ... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Chron... Recurrent Plasm... Recurrent Small... Refractory Chil... Refractory Chro... Refractory Non-... Refractory Plas... Refractory Smal... t(14;16) t(4;14) T-Cell Prolymph... Waldenstrom Mac...	Allogeneic Bone... Allogeneic Hema... Autologous Hema... Autologous-Allo... Carmustine Cyclophosphamid... Cytarabine Etoposide Fludarabine Pho... Laboratory Biom... Melphalan Mycophenolate M... Peripheral Bloo... Tacrolimus Total-Body Irra...	- 75 Years	Fred Hutchinson Cancer Center
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia	NCT00093743	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Myelo... Fanconi Anemia Previously Trea...	fludarabine pho... cyclosporine total-body irra... allogeneic bone... allogeneic hema... peripheral bloo... mycophenolate m...	-	Fred Hutchinson Cancer Center
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome	NCT00002547	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine cytarabine methotrexate allogeneic bone... syngeneic bone ...	- 60 Years	Barbara Ann Karmanos Cancer Institute
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia	NCT00002658	Leukemia Neutropenia	filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome	NCT00002798	Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... Chronic Myelomo... de Novo Myelody... Refractory Anem... Refractory Anem... Refractory Anem... Refractory Anem... Secondary Myelo... Untreated Child...	asparaginase daunorubicin hy... fludarabine pho... therapeutic hyd... allogeneic bone... 3-dimensional c... filgrastim cytarabine idarubicin dexamethasone thioguanine etoposide methotrexate cyclophosphamid... aldesleukin busulfan	- 21 Years	National Cancer Institute (NCI)
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS	NCT01300572	Chronic Myelomo... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Secondary Acute...	Allogeneic Bone... Allogeneic Hema... Cyclosporine Fludarabine Pho... Indium In 111 A... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Pharmacological... Total-Body Irra... Yttrium Y 90 An...	18 Years -	Fred Hutchinson Cancer Center
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia	NCT00002771	Leukemia	recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera...	-	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia	NCT00022126	Leukemia	asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate methylprednisol... pegaspargase thioguanine vincristine sul... allogeneic bone... radiation thera...	- 1 Year	Children's Oncology Group
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma	NCT01440556	Multiple Myelom... Allogeneic Tran...		18 Years - 80 Years	Azienda Ospedaliera San Giovanni Battista
Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia	NCT00002844	Leukemia	Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra...	16 Years - 65 Years	M.D. Anderson Cancer Center
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma	NCT00003060	Melanoma (Skin)	filgrastim busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone...	16 Years - 44 Years	Louisiana State University Health Sciences Center Shreveport
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia	NCT00004181	Chronic Myelopr... Leukemia Multiple Myelom...	busulfan cyclophosphamid... allogeneic bone... radiation thera...	15 Years - 55 Years	Northwestern University
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia	NCT00003868	Leukemia	cyclophosphamid... methotrexate allogeneic bone... peripheral bloo... iodine I 131 mo... radiation thera...	2 Years - 55 Years	Fred Hutchinson Cancer Center
Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia	NCT00002961	Leukemia	cyclophosphamid... cyclosporine etoposide methotrexate allogeneic bone... Total Body Irra... Busulfan Mesna Radiation	- 21 Years	Children's Hospital of Philadelphia
Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma	NCT00998270	Multiple Myelom...	Autologous bone... Allogeneic bone...	18 Years - 55 Years	Tehran University of Medical Sciences
Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia	NCT00002961	Leukemia	cyclophosphamid... cyclosporine etoposide methotrexate allogeneic bone... Total Body Irra... Busulfan Mesna Radiation	- 21 Years	Children's Hospital of Philadelphia
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia	NCT00002831	Leukemia	Filgrastim Busulfan Cyclophosphamid... Cyclosporine Decitabine (DAC... Methotrexate Methylprednisol... Tacrolimus Allogeneic Bone... Peripheral Bloo...	15 Years - 55 Years	M.D. Anderson Cancer Center
Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma	NCT00998270	Multiple Myelom...	Autologous bone... Allogeneic bone...	18 Years - 55 Years	Tehran University of Medical Sciences
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia	NCT00093587	Graft Versus Ho... Leukemia	anti-thymocyte ... busulfan cyclophosphamid... cyclosporine allogeneic bone... peripheral bloo... radiation thera...	18 Years - 55 Years	National Cancer Institute (NCI)
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia	NCT00002700	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone prednisone therapeutic hyd... vincristine sul... allogeneic bone... autologous bone... radiation thera...	15 Years - 60 Years	European Organisation for Research and Treatment of Cancer - EORTC
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases	NCT00450450	Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Phase C... de Novo Myelody... Juvenile Myelom... Previously Trea... Recurrent Child... Secondary Myelo...	allogeneic bone... laboratory biom... filgrastim	- 21 Years	Children's Oncology Group
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease	NCT00295971	Congenital Ameg... Leukemia Myelodysplastic... Severe Congenit...	anti-thymocyte ... therapeutic all... fludarabine pho... thiotepa allogeneic bone... allogeneic hema... in vitro-treate... total-body irra...	1 Year - 17 Years	University of California, San Francisco
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia	NCT00027547	Leukemia	therapeutic all... cyclosporine cytarabine fludarabine pho... methotrexate mycophenolate m... allogeneic bone... peripheral bloo... radiation thera...	- 75 Years	Fred Hutchinson Cancer Center
Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer	NCT00534430	Leukemia Myelodysplastic...	busulfan cyclosporine etoposide mycophenolate m... allogeneic bone... allogeneic hema... peripheral bloo... total-body irra...	16 Years - 50 Years	City of Hope Medical Center
S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma	NCT00121186	Lymphoma	fludarabine pho... melphalan methotrexate tacrolimus allogeneic bone... peripheral bloo...	18 Years -	SWOG Cancer Research Network
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant	NCT00107354	Leukemia Myelodysplastic...	aldesleukin therapeutic all... therapeutic aut... cytarabine etoposide mitoxantrone hy... allogeneic bone... peripheral bloo...	14 Years -	Fred Hutchinson Cancer Center
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT01707004	Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Previously Trea... Recurrent Adult... Secondary Acute...	decitabine fludarabine pho... busulfan cyclophosphamid... tacrolimus mycophenolate m... filgrastim total-body irra... allogeneic bone... laboratory biom...	18 Years - 75 Years	University of Wisconsin, Madison
Bone Marrow Transplantation in Treating Patients With Leukemia	NCT00006451	Graft Versus Ho... Leukemia Lymphoma	anti-thymocyte ... cyclophosphamid... cyclosporine methotrexate methylprednisol... allogeneic bone... in vitro-treate... radiation thera...	- 45 Years	Masonic Cancer Center, University of Minnesota
Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma	NCT00720447	Lymphoma	alemtuzumab donor lymphocyt... carmustine cytarabine etoposide melphalan allogeneic bone... peripheral bloo...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma	NCT00004231	Lymphoma	aldesleukin filgrastim recombinant int... busulfan cyclophosphamid... cytarabine doxorubicin hyd... leucovorin calc... methotrexate prednisone teniposide vincristine sul... allogeneic bone... autologous bone... peripheral bloo...	18 Years -	Northwestern University
Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation	NCT00609739	Leukemia	cyclosporine cytarabine filgrastim methotrexate methylprednisol... mitoxantrone hy... allogeneic bone... umbilical cord ... Cis-Retinoic ac...	- 18 Years	Masonic Cancer Center, University of Minnesota
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation	NCT00002456	Graft Versus Ho... Leukemia Lymphoma	cyclosporine methotrexate allogeneic bone...	-	Fred Hutchinson Cancer Center
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome	NCT00024050	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone... peripheral bloo...	- 65 Years	Fred Hutchinson Cancer Center
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders	NCT00553098	Immunodeficienc... Non-Cancer Diag...	Alemtuzumab Allogeneic Bone... Allogeneic Hema... Cyclosporine Fludarabine Pho... Laboratory Biom... Mycophenolate M... Total-Body Irra...	- 54 Years	Fred Hutchinson Cancer Center
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS	NCT01300572	Chronic Myelomo... Previously Trea... Recurrent Adult... Recurrent Adult... Refractory Anem... Secondary Acute...	Allogeneic Bone... Allogeneic Hema... Cyclosporine Fludarabine Pho... Indium In 111 A... Laboratory Biom... Mycophenolate M... Peripheral Bloo... Pharmacological... Total-Body Irra... Yttrium Y 90 An...	18 Years -	Fred Hutchinson Cancer Center
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy	NCT00070174	Leukemia	asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide gemtuzumab ozog... methotrexate mitoxantrone hy... allogeneic bone...	-	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome	NCT00002805	Leukemia	filgrastim cladribine cytarabine etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... autologous bone... peripheral bloo... low-LET cobalt-... low-LET electro... low-LET photon ...	- 21 Years	Children's Oncology Group
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia	NCT00003436	Leukemia Myelodysplastic...	amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone...	- 15 Years	National Cancer Institute (NCI)
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)	NCT04965597	Bone Marrow Fai... Congenital Ameg... Congenital Pure... Hereditary Side... Paroxysmal Noct... Shwachman-Diamo... Hematologic Neo... Hematologic Neo... Hematologic Neo...	Treosulfan Fludarabine Pho... Tacrolimus Methotrexate Lapine T-Lympho... Peripheral Bloo... Allogeneic Bone... Quality-of-Life... Echocardiograph... Multigated Acqu... Bone Marrow Bio... Bone Marrow Asp... Biospecimen Col...	1 Year - 49 Years	Fred Hutchinson Cancer Center
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma	NCT00995059	Multiple Myelom... Refractory Mult...	nonmyeloablativ... allogeneic bone... bortezomib melphalan anti-thymocyte ... sirolimus tacrolimus total-body irra...	18 Years -	Mayo Clinic
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma	NCT00003728	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisolone therapeutic hyd... thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo...	- 17 Years	National Cancer Institute (NCI)
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma	NCT00002552	Lymphoma Multiple Myelom...	filgrastim sargramostim carmustine cyclophosphamid... cytarabine etoposide leucovorin calc... methotrexate perfosfamide therapeutic hyd... allogeneic bone... autologous bone... in vitro-treate... peripheral bloo... syngeneic bone ... radiation thera...	- 70 Years	Barbara Ann Karmanos Cancer Institute
Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery	NCT00243009	Kidney Cancer	cyclosporine fludarabine pho... mycophenolate m... allogeneic bone... peripheral bloo... radiation thera...	18 Years - 75 Years	OHSU Knight Cancer Institute
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy	NCT00070174	Leukemia	asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide gemtuzumab ozog... methotrexate mitoxantrone hy... allogeneic bone...	-	Children's Oncology Group
Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission	NCT00005940	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye...	iodine I 131 mo... busulfan cyclophosphamid... allogeneic bone... allogeneic hema... peripheral bloo... cyclosporine methotrexate laboratory biom...	16 Years - 55 Years	Fred Hutchinson Cancer Center
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia	NCT00002701	Leukemia	busulfan cyclophosphamid... cytarabine etoposide idarubicin mercaptopurine methotrexate mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... radiation thera...	16 Years - 74 Years	National Cancer Institute (NCI)
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients	NCT00824993	Hematological M...	Ibandronate Vitamin Supplem...	18 Years -	M.D. Anderson Cancer Center
Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation	NCT00609739	Leukemia	cyclosporine cytarabine filgrastim methotrexate methylprednisol... mitoxantrone hy... allogeneic bone... umbilical cord ... Cis-Retinoic ac...	- 18 Years	Masonic Cancer Center, University of Minnesota
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia	NCT00003758	Leukemia	cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo...	15 Years - 60 Years	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: